• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 47
      Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials - 5 month(s) ago

      We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.

      Source: www.thelancet.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	TheLancetEndo
        TheLancetEndo

        New—Effects of #GLP-1 receptor agonists on #kidney and #cardiovascular disease outcomes: a meta-analysis of randomised controlled trials https://t.co/aVZ4Kcd3Bb #T2D #CVD

    • Mashup Score: 47
      Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials - 6 month(s) ago

      We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.

      Source: www.thelancet.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	TheLancetEndo
        TheLancetEndo

        New—Effects of #GLP-1 receptor agonists on #kidney and #cardiovascular disease outcomes: a meta-analysis of randomised controlled trials https://t.co/aVZ4Kcd3Bb #T2D #CVD

    • Mashup Score: 47
      Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials - 6 month(s) ago

      We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.

      Source: www.thelancet.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	TheLancetEndo
        TheLancetEndo

        New—Effects of #GLP-1 receptor agonists on #kidney and #cardiovascular disease outcomes: a meta-analysis of randomised controlled trials https://t.co/aVZ4Kcd3Bb #T2D #CVD

    • Mashup Score: 47
      Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials - 6 month(s) ago

      We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.

      Source: www.thelancet.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	TheLancetEndo
        TheLancetEndo

        New—Effects of #GLP-1 receptor agonists on #kidney and #cardiovascular disease outcomes: a meta-analysis of randomised controlled trials https://t.co/aVZ4Kcd3Bb #T2D #CVD

    • Mashup Score: 47
      Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials - 7 month(s) ago

      We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.

      Source: www.thelancet.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	TheLancetEndo
        TheLancetEndo

        New—Effects of #GLP-1 receptor agonists on #kidney and #cardiovascular disease outcomes: a meta-analysis of randomised controlled trials https://t.co/aVZ4Kcd3Bb #T2D #CVD

    • Mashup Score: 47
      Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials - 7 month(s) ago

      We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.

      Source: www.thelancet.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	TheLancetEndo
        TheLancetEndo

        New—Effects of #GLP-1 receptor agonists on #kidney and #cardiovascular disease outcomes: a meta-analysis of randomised controlled trials https://t.co/aVZ4Kcd3Bb #T2D #CVD

    • Mashup Score: 47
      Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials - 7 month(s) ago

      We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.

      Source: www.thelancet.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	TheLancetEndo
        TheLancetEndo

        New—Effects of #GLP-1 receptor agonists on #kidney and #cardiovascular disease outcomes: a meta-analysis of randomised controlled trials https://t.co/aVZ4Kcd3Bb #T2D #CVD

    • Mashup Score: 47
      Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials - 7 month(s) ago

      We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.

      Source: www.thelancet.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	TheLancetEndo
        TheLancetEndo

        New—Effects of #GLP-1 receptor agonists on #kidney and #cardiovascular disease outcomes: a meta-analysis of randomised controlled trials https://t.co/aVZ4Kcd3Bb #T2D #CVD

    • Mashup Score: 47
      Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials - 7 month(s) ago

      We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.

      Source: www.thelancet.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	TheLancetEndo
        TheLancetEndo

        New—Effects of #GLP-1 receptor agonists on #kidney and #cardiovascular disease outcomes: a meta-analysis of randomised controlled trials https://t.co/aVZ4Kcd3Bb #T2D #CVD

    • Mashup Score: 47
      Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials - 7 month(s) ago

      We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.

      Source: www.thelancet.com
      Categories: General Medicine News, Endocrinology
      Tweet Tweets with this article
      • Profile photo of 	TheLancetEndo
        TheLancetEndo

        New—Effects of #GLP-1 receptor agonists on #kidney and #cardiovascular disease outcomes: a meta-analysis of randomised controlled trials https://t.co/aVZ4Kcd3Bb #T2D #CVD

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings